Skip to main content
FinSpry Logo
FinSpry
NVO logo
NVO
(NYSE)
Novo Nordisk A/S
$48.18-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Novo Nordisk A/S (NVO) Stock Price & Financial Analysis

Novo Nordisk A/S Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$48.11 - $48.93
52-Week High$71.80
52-Week Low$35.12
Open$48.39
Volume8.12M
Average Volume (3M)10.62M
Market Cap214.34B
Shares Outstanding4.45B
P/E Ratio (TTM)11.53
Forward P/E9.89
Price to Sales (P/S)4.29
Price to Book (P/B)6.92
EV/EBITDA8.48
Revenue (TTM)49.98B
Net Income (TTM)18.59B
Free Cash Flow (TTM)5.25B
EPS (TTM)$4.18
Profit Margin37.20%
Operating Margin45.30%
Return on Equity (ROE)60.06%
Debt to Equity0.72
50-Day MA$46.31
200-Day MA$47.20
52-Week Change-31.20%
Annual Dividend$2.94
Dividend Yield6.11%
Payout Ratio70.42%
Last Dividend Ex-DateApr 8, 2027

Frequently Asked Questions About Novo Nordisk A/S

What is the current stock price for NVO?

As of the latest trading session, NVO stock trades at $48.18. The 52-week range is $35.12–$71.80, with a day range of $48.11–$48.93.

What is the P/E ratio for NVO?

Novo Nordisk A/S's trailing P/E ratio is 11.5, meaning investors pay $11.5 for every $1 of annual earnings. The forward P/E is 9.9, reflecting analyst expectations for future earnings. Novo Nordisk A/S operates in the Healthcare sector.

Does NVO pay dividends?

Yes, Novo Nordisk A/S pays a 6.11% annual dividend yield ($2.94 per share). The payout ratio is 70.4%. The last ex-dividend date was 2027-04-08.

What do analysts recommend for NVO?

Based on 4 analysts, the consensus for NVO is Hold.

What is the market cap of NVO?

Novo Nordisk A/S's market capitalization is $214.34B, classifying it as a mega-cap company. Novo Nordisk A/S operates in the Healthcare sector within the Drug Manufacturers - General industry.